by Benzinga Insights | Dec 12, 2025 | General
First Solar (NASDAQ:FSLR) has outperformed the market over the past 10 years by 2.01% on an annualized basis producing an average annual return of 14.78%. Currently, First Solar has a market capitalization of $29.40 billion. Buying $1000 In FSLR: If an investor had...
by Vandana Singh | Dec 12, 2025 | General
The U.S. Food and Drug Administration (FDA) on Thursday approved Amgen Inc.’s (NASDAQ:AMGN) Uplinza (inebilizumab-cdon) for generalized myasthenia gravis (gMG). The approval covers adult patients who are anti-acetylcholine receptor (AChR) and anti-muscle-specific...
by Henry Khederian | Dec 12, 2025 | General
Canopy Growth Corp (NASDAQ:CGC) shares are skyrocketing Friday morning, driven by reports that President Donald Trump intends to relax federal marijuana regulations. Canopy Growth stock is surging to new heights today. Why are CGC shares rallying? What To Know: The...
by Dylan Berman | Dec 12, 2025 | General
Tilray Brands, Inc. (NASDAQ:TLRY) shares are trading higher Friday following a report suggesting that President Donald Trump is expected to reclassify marijuana as a Schedule III drug. Tilray Brands stock is charging ahead with explosive momentum. What’s fueling TLRY...
by Anusuya Lahiri | Dec 12, 2025 | General
Taiwan ramped up its artificial intelligence ambitions on Friday as President Lai Ching-te inaugurated a new cloud computing center built around one of the island’s most powerful supercomputers. Lai Ching-te on Friday opened a new cloud computing center equipped with...
by Surbhi Jain | Dec 12, 2025 | General
Cannabis stocks haven’t moved like this in years, and it took a rare one-two punch to jolt the sector back to life: a Washington Post scoop hinting that President Donald Trump wants to reclassify marijuana into Schedule III — and a Tilray Brands Inc...
Recent Comments